1. Home
  2. XBIT vs MRCC Comparison

XBIT vs MRCC Comparison

Compare XBIT & MRCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo XBiotech Inc.

XBIT

XBiotech Inc.

HOLD

Current Price

$2.30

Market Cap

71.3M

Sector

Health Care

ML Signal

HOLD

Logo Monroe Capital Corporation

MRCC

Monroe Capital Corporation

HOLD

Current Price

$4.58

Market Cap

100.1M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
XBIT
MRCC
Founded
2005
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Pharmaceuticals and Biotechnology
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
71.3M
100.1M
IPO Year
2015
2011

Fundamental Metrics

Financial Performance
Metric
XBIT
MRCC
Price
$2.30
$4.58
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
45.1K
152.8K
Earning Date
05-13-2026
03-05-2026
Dividend Yield
N/A
7.83%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.09
$4.11
52 Week High
$3.62
$7.76

Technical Indicators

Market Signals
Indicator
XBIT
MRCC
Relative Strength Index (RSI) 51.97 39.37
Support Level $2.32 $4.11
Resistance Level $2.49 $4.97
Average True Range (ATR) 0.08 0.21
MACD 0.01 0.05
Stochastic Oscillator 66.69 30.77

Price Performance

Historical Comparison
XBIT
MRCC

About XBIT XBiotech Inc.

XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.

About MRCC Monroe Capital Corporation

Monroe Capital Corp is a speciality finance company focused on providing financing to lower middle-market companies, in the United States and Canada. The company provides customized financing solutions focused on senior, unitranche, and junior secured debt and unsecured subordinated debt and equity, including equity co-investments in preferred and common stock and warrants. Its investment objective is to maximize the total return to its stockholders in the form of current income and capital appreciation through investment in senior secured, unitranche secured and junior secured debt and, to a lesser extent, unsecured subordinated debt and equity investments.

Share on Social Networks: